Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
Media & Investors
Transparency is important to us. Find important information about Kuros Biosciences here – from our corporate documents to our current share price.
Press releases
Here are our latest press releases.
For archived news items, please go to our Resources center. To subscribe to receive our press releases, please click here.
12 Oct 2023
Adhoc Press Release
Kuros reports a 150% increase in direct MagnetOs sales in the first nine months of 2023 and announces changes within the Executive Management
08 May 2023
Adhoc Press Release
Annual General Meeting of Kuros Biosciences approves all resolutions
Investor calendar
| Date | Event |
|---|---|
| Mar 13, 2024 | Publish Financial Report 2023 |
| Apr 24, 2024 | Trading Update Q1 2024 |
Reports, Corporate Governance & Meetings
Kuros Biosciences is fully committed to good corporate governance and adherence to high ethical standards. Our principles and rules on corporate governance and ethical conduct are articulated in the Articles of Association, the Internal Regulations, the charters of the committees of our board of directors, and our code of conduct.
Analysts
For more information regarding analyst reports, please contact:
Laura Pfeifer-Rossi
Octavian AG
sales@octavian.ch
Tel: +41 44 520 1588
Want to receive our press releases?